Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 5, 2014, Pages 1171-1180

  Clements, Karen M ^a   Meier, Genevieve ^b   McGarry, Lisa J ^a   Pruttivarasin, Narin ^a   Misurski, Derek A ^b  

^a OPTUM   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Cost effectiveness; Influenza; Markov model; Quadrivalent inactivated vaccine; United States

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR; TRIPLE VACCINE; ZANAMIVIR; INACTIVATED VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MIDDLE AGED; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PROBABILITY; PRODUCTIVITY; QUALITY OF LIFE; SCHOOL CHILD; SENSITIVITY ANALYSIS; UNITED STATES; COST BENEFIT ANALYSIS; ECONOMICS; INFLUENZA, HUMAN; PROCEDURES; STATISTICAL MODEL; VACCINATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; MODELS, ECONOMIC; UNITED STATES; VACCINATION; VACCINES, INACTIVATED; YOUNG ADULT;

EID: 84901404002     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.28221     Document Type: Article

References (55)

1. Centers for Disease Control and Prevention (CDC). Seasonal Influenza (Flu): Questions & Answers. Available from: http://www.cdc.gov/flu/about/qa/ preventingflu.htm
2. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25:5086-96; PMID:17544181; http://dx.doi.org/10.1016/j.vaccine.2007.03.046
3. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, et al.; Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59(RR-8):1-62; PMID:20689501
4. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) - United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep 2012; 61:613-8; PMID:22895385
5. Centers for Disease Control and Prevention (CDC). Flu Activity & Surveillance Reports.
6. Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine 2012; 30:1993-8; PMID:22226861; http://dx.doi.org/10.1016/j.vaccine. 2011.12.098
7. Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2008; CD004879; PMID:18425905
8. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44; PMID:22032844; http://dx.doi.org/10.1016/ S1473-3099(11)70295-X
9. Gold MR, Siegel JE, Russel LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. Oxford University Press, 1996.
10. NACI Members. Canada Communicable Disease Report. Canada: Public Health Agency, Canada. Fluwatch: www.publichealth.gc.ca. Accessed; 21 Jan 2014.
11. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-86; PMID:12517228; http://dx.doi.org/10.1001/ jama.289.2.179
12. Chowell G, Miller MA, Viboud C. Seasonal influenza in the United States, France, and Australia: transmission and prospects for control. Epidemiol Infect 2008; 136:852-64; PMID:17634159; http://dx.doi.org/10.1017/S0950268807009144
13. Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine 1999; 17(Suppl 1):S3-10; PMID:10471173; http://dx.doi.org/10.1016/S0264- 410X(99)00099-7
14. Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal influenza - United States, 1976-2007. MMWR Morb Mortal Wkly Rep 2010; 59:1057-62; PMID:20798667
15. Zhou H, Thompson WW, Viboud CG, Ringholz CM, Cheng PY, Steiner C, Abedi GR, Anderson LJ, Brammer L, Shay DK. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis 2012; 54:1427-36; PMID:22495079; http://dx.doi.org/10.1093/cid/cis211
16. Lee BY, Bartsch SM, Willig AM. The economic value of a quadrivalent versus trivalent influenza vaccine. Vaccine 2012; 30:7443-6; PMID:23084849; http://dx.doi.org/10.1016/j.vaccine.2012.10.025
17. Lee BY, Bartsch SM, Willig AM. Corrigendum to "The economic value of a quadrivalent versus trivalentinñuenza vaccine" [Vaccine 30 (2012) 7443-7446]. Vaccine 2013; 31:2477-9; http://dx.doi.org/10.1016/j.vaccine.2013. 04.013
18. Tricco AC, Chit A, Soobiah C, Hallett D, Meier G, Chen MH, Tashkandi M, Bauch CT, Loeb M. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med 2013; 11:153; PMID:23800265; http://dx.doi.org/10.1186/1741-7015-11-153
19. DiazGranados CA, Denis M, Plotkin S. Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. Vaccine 2012; 31:49-57; PMID:23142300; http://dx.doi.org/10.1016/j.vaccine.2012.10.084
20. Belshe RB. The need for quadrivalent vaccine against seasonal influenza. Vaccine 2010; 28(Suppl 4):D45-53; PMID:20713260; http://dx.doi.org/10.1016/j. vaccine.2010.08.028
21. Irving SA, Patel DC, Kieke BA, Donahue JG, Vandermause MF, Shay DK, Belongia EA. Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004-2005 through 2007-2008. Influenza Other Respir Viruses 2012; 6:37-43; PMID:21668663; http://dx.doi.org/10.1111/j.1750-2659.2011.00263.x
22. Olson DR, Heffernan RT, Paladini M, Konty K, Weiss D, Mostashari F. Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Med 2007; 4:e247; PMID:17683196; http://dx.doi.org/10.1371/journal.pmed.0040247
23. Monto AS, Davenport FM, Napier JA, Francis T Jr. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis 1970; 122:16-25; PMID:5433709; http://dx.doi.org/10.1093/infdis/122. 1-2.16
24. Hite LK, Glezen WP, Demmler GJ, Munoz FM. Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus. Int J Infect Dis 2007; 11:40-7; PMID:16678464; http://dx.doi.org/10.1016/j.ijid. 2005.10.008
25. Weycker D, Edelsberg J, Halloran ME, Longini IM Jr., Nizam A, Ciuryla V, Oster G. Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005; 23:1284-93; PMID:15652671; http://dx.doi.org/10.1016/j. vaccine.2004.08.044
26. Hull HF, McBean M, O'Connor H. Assessment of herd immunity in the elderly following vaccination of school children with live, attenuated influenza vaccine. Infectious Disease Society of America 48th Annual Meeting, Vancouver, Canada 2010.
27. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001; 344:889-96; PMID:11259722; http://dx.doi.org/10.1056/ NEJM200103223441204
28. Ghendon YZ, Kaira AN, Elshina GA. The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly. Epidemiol Infect 2006; 134:71-8; PMID:16316494; http://dx.doi.org/10.1017/ S0950268805005650
29. Centers for Disease Control and Prevention (CDC). Final estimates for 2009-10 Seasonal Influenza and Influenza A (H1N1) 2009 Monovalent Vaccination Coverage - United States, August 2009 through May, 2010. Available from: http://www.cdc.gov/flu/fluvaxview/coverage-0910estimates.htm.
30. Centers for Disease Control and Prevention (CDC). Final state-level influenza vaccination coverage estimates for the 2010-11 season - United States, National Immunization Survey and Behavioral Risk Factor Surveillance System, August 2010 through May 2011. Available from: http://www.cdc.gov/flu/fluvaxview/ coverage-1011estimates.htm
31. Centers for Disease Control and Prevention (CDC). Seasonal influenza vaccination coverage among children aged 6 months-18 years - eight immunization information system sentinel sites, United States, 2009-10 influenza season. MMWR Morb Mortal Wkly Rep 2010; 59:1266-9; PMID:20930704
32. Aballéa S, Chancellor J, Martin M, Wutzler P, Carrat F, Gasparini R, Toniolo-Neto J, Drummond M, Weinstein M. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model. Value Health 2007; 10:98-116; PMID:17391419; http://dx.doi.org/10.1111/j.1524-4733.2006. 00157.x
33. US Census Bureau. 2011.
34. Merrill RM, Beard JD. Influenza vaccination in the United States, 2005-2007. Med Sci Monit 2009; 15:PH92-100; PMID:19564838
35. Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010; CD004876; PMID:20166072
36. Jefferson T, Di Pietrantonj C, Rivetti A, Bawazeer GA, Al-Ansary LA, Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2010; CD001269; PMID:20614424
37. Bloom B, Cohen RA, Freeman G. Summary health statistics for U.S. children: National Health Interview Survey. Vital and health statistics Series 10. 2009; 1-81
38. Centers for Disease Control and Prevention (CDC). Influenza vaccination levels among persons aged > or =65 years and among persons aged 18-64 years with high-risk conditions - United States, 2003. MMWR Morb Mortal Wkly Rep 2005; 54:1045-9; PMID:16237375
39. Dharan NJ, Beekmann SE, Fiore A, Finelli L, Uyeki TM, Polgreen PM, Fry AM. Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses. Antiviral Res 2010; 88:182-6; PMID:20739002; http://dx.doi.org/10.1016/j.antiviral.2010.08.010
40. Heikkinen T, Silvennoinen H, Peltola V, Ziegler T, Vainionpaa R, Vuorinen T, Kainulainen L, Puhakka T, Jartti T, Toikka P, et al. Burden of influenza in children in the community. J Infect Dis 2004; 190:1369-73; PMID:15378427; http://dx.doi.org/10.1086/424527
41. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenzarelated lower respiratory tract complications and hospitalizations. Arch Intern Med 2003; 163:1667-72; PMID:12885681; http://dx.doi.org/10.1001/archinte.163.14.1667
42. Burch J, Paulden M, Conti S, Stock C, Corbett M, Welton NJ, Ades AE, Sutton A, Cooper N, Elliot AJ, et al. Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation. [iii-iv.]. Health Technol Assess 2009; 13:1-265, iii-iv; PMID:19954682
43. IMS Health, DDD(tm). Total Sales 2011. 2012.
44. 2010 VFC Eligible Children. Data on file.
45. Physicians Fee & Coding Guide 2011. Mag Mutual Healthcare Solutions.
46. Centers for Medicare & Medicaid Services. VFC Comparison of Regional Maximum Rate for Vaccine Administration to Current State Rate.
47. United States Census Bureau. Health Insurance Coverage Status and Type of Coverage - All Persons by Age and Sex: 1999 to 2012. Available from: http://www.census.gov/hhes/www/hlthins/data/historical/files/hihistt3B.xls.
48. Book R. 2011 Pharmacy Fundamental Reference. Montvale, NJ: Thomson, 2011.
49. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333-40; PMID:15367555; http://dx.doi.org/10.1001/jama.292.11.1333
50. Bureau of Labor Statistics. Employment, Hours, and Earnings from the Current Employment Statistics Survey (National) 2006-2012
51. Hanmer J, Lawrence WF, Anderson JP, Kaplan RM, Fryback DG. Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. Med Decis Making 2006; 26:391-400; PMID:16855127; http://dx.doi.org/10.1177/0272989X06290497
52. Arias E. United States life tables, 2006. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics. National Vital Statistics System 2010; 58:1-40
53. World Health Organization. Cost-effectiveness thresholds. Available from: http://www.who.int/choice/costs/CER-thresholds/en/
54. Economics T. United states GDP per capita PPP. Available from: http://www.tradingeconomics.com/united-states/gdp-per-capita-ppp
55. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making 1985; 5:157-77; PMID:3831638; http://dx.doi.org/10.1177/ 0272989X8500500205